Financials

  • Market Capitalization 53.04 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.18
Rapporto prezzo/fatturato
6.16

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4253
BYSI
BeyondSpring, Inc. - Ordinary Shares
1.33 USD0.00%-18.90%-17.39%-41.41%54.69 M USD
4261
INMB
INmune Bio Inc. - Common stock
2.02 USD+8.60%+16.09%+56.59%-1.94%53.70 M USD
4272
XLO
Xilio Therapeutics, Inc. - Common Stock
9.03 USD-2.27%-1.20%+6.24%+1136.99%52.22 M USD
4279
MCRB
Seres Therapeutics, Inc. - Common Stock
5.34 USD-4.98%-32.49%-5.32%-35.12%51.19 M USD

Notizie